ArticlebioRxiv : the preprint server for biology2025

Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia.

Bogdan Popescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.